InvestorsHub Logo

CallMeCrazy

04/11/19 12:12 PM

#260303 RE: DaubersUP #260301

Leo's incentive to further withhold B-absssi


a group of drugmakers, public health organizations and doctors said in a letter to US lawmakers on Tuesday, urging Senators to take a fresh approach to stimulate antimicrobial drug development by enacting policy measures to increase the value of a marketed antibiotic.
Beyond the incentives already in place to push drugmakers to develop antibiotics, the group urged the passage of “pull incentives,” or policy measures to increase the value of a marketed antibiotic by rewarding drugmakers only after their antibiotic is approved by the FDA.



IMO, Leo should wait on more lucrative "pull incentives" before advancing B-absssi into a P3. B has lots of other indications (OM, IBD, etc) that he can work on bringing to market in the meantime.

It seems he's doing just that.
https://endpts.com/to-tackle-superbug-scourge-and-revive-rd-incentivize-fda-antibiotic-approvals-drugmakers-health-groups-urge-us-lawmakers/

DauberUP: I agree. Let's close green and strong.

Message in reply to:
Big volume!!! Let’s close green and strong!!

JTORENCE

04/11/19 12:31 PM

#260306 RE: DaubersUP #260301

Not today.imo